Aortic plaque regression as determined by magnetic resonance imaging with high-dose and low-dose statin therapy

J Cardiovasc Med (Hagerstown). 2008 Jul;9(7):700-6. doi: 10.2459/JCM.0b013e3282f447c3.

Abstract

Objective: We sought to compare the effects of high-dose with low-dose simvastatin therapy on aortic plaque morphology using transoesophageal magnetic resonance imaging (TEMRI).

Methods: Thirty-one patients with established moderate-to-severe atherosclerosis were recruited and randomized to 80 versus 20 mg/day simvastatin therapy. Aortic vessel wall and lumen volumes and areas were measured by TEMRI at baseline and 12 months.

Results: Significant differences were observed between the low-dose and high-dose statin therapy in reduction of low-density lipoprotein cholesterol (LDL-c) (10 mg/dl, P = 0.001), total cholesterol (16.2 mg/dl, P < 0.001), vessel wall area (19.0 mm2, P < 0.001) and volume (343.4 mm3, P < 0.001), as well as increase in lumen area (54.4 mm2, P < 0.001) and volume (1038 mm3, P < 0.001). LDL-c lowering was significantly associated with aortic wall area and volume reduction in both groups.

Conclusion: High-dose statin leads to greater LDL-c reduction, aortic vessel wall reduction and lumen increase than low-dose statin therapy in patients with at least moderate-documented atherosclerosis.

Trial registration: ClinicalTrials.gov NCT00125060.

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aortic Diseases / drug therapy*
  • Aortic Diseases / pathology*
  • Arteriosclerosis / drug therapy*
  • Arteriosclerosis / pathology*
  • Cholesterol / blood
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage*
  • Image Processing, Computer-Assisted
  • Magnetic Resonance Imaging, Cine
  • Male
  • Simvastatin / administration & dosage*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Cholesterol
  • Simvastatin

Associated data

  • ClinicalTrials.gov/NCT00125060